Nras Mutant Advanced Cutaneous Melanoma clinical trials

Explore recruiting nras mutant advanced cutaneous melanoma clinical trials.

Recruiting nras mutant advanced cutaneous melanoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nras Mutant Advanced Cutaneous Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Belvarafenib as a Single Agent and in Combination with Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients with NRAS-Mutant Advanced Melanoma

Germany, Norway

Human Pharmacology (Phase I)- Other EU CTIS Study details

Nras Mutant Advanced Cutaneous Melanoma trials by city

Nras Mutant Advanced Cutaneous Melanoma in Toronto Nras Mutant Advanced Cutaneous Melanoma in Vancouver Nras Mutant Advanced Cutaneous Melanoma in Montreal Nras Mutant Advanced Cutaneous Melanoma in Calgary Nras Mutant Advanced Cutaneous Melanoma in Edmonton Nras Mutant Advanced Cutaneous Melanoma in Ottawa Nras Mutant Advanced Cutaneous Melanoma in Winnipeg Nras Mutant Advanced Cutaneous Melanoma in Quebec City Nras Mutant Advanced Cutaneous Melanoma in Hamilton Nras Mutant Advanced Cutaneous Melanoma in Kitchener Nras Mutant Advanced Cutaneous Melanoma in London Nras Mutant Advanced Cutaneous Melanoma in Halifax Nras Mutant Advanced Cutaneous Melanoma in New York Nras Mutant Advanced Cutaneous Melanoma in Los Angeles Nras Mutant Advanced Cutaneous Melanoma in Chicago Nras Mutant Advanced Cutaneous Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease